$15 Million
In Re: Avandia Marketing, Sales Practices and Product Liability Litigation
Mass Plaintiff,Product Liability,Unfair Business Practices
Attorneys:
Mike Arias
Case Synopsis
Arias Sanguinetti represented several patients who suffered heart failure or stroke after taking the diabetes drug Avandia. Lawsuits alleged that GlaxoSmithKline failed to adequately warn patients and doctors about the drug’s cardiovascular risks.
Beginning in 2007, after studies raised concerns about increased risks of heart attack, thousands of claims were filed across the country. Our firm represented clients in the resulting multidistrict litigation and helped secure over $15 million in compensation for those harmed.
These settlements provided meaningful relief to individuals who relied on Avandia to manage their diabetes, only to experience life-altering injuries.
"When powerful pharmaceutical companies put profits over people, justice must speak louder. Our fight in the Avandia litigation sent a clear message: accountability matters."
